Objective: This study was designed to evaluate patients treated with subureteric injection (STING) and ureteroneocystostomy by the Lich-Gregoir technique (LGT) due to vesicoureteral reflux (VUR) in terms of radiologic, scintigraphic images, laboratory findings and bladder functions and determine the effectiveness of both treatment modalities.
INTRODUCTION
Self-amended treatment of VUR is performed either surgically or with endoscopy. In the treatment of VUR, STING is another treatment option. A subureteral dextranomer / hyaluronic acid injection has become the most widely used substance treatment option worldwide in endoscopic therapy [1] . An open surgical procedure can be performed if attempts to treat VUR with injection therapy fail [2] .
The most commonly used ureteroneocystostomy techniques are the Politano-Leadbetter, Cohen, and
LGT. The aim of surgery is to create a submucosal tunnel which is at least 5 times the size of the ureteral orifice in the bladder. The technique known as the LGT was used by Lich for the first time in 1961, then Gregoir made slight modifications. The most important advantage is the absence of bladder spasm and hematuria as bladder mucosa is not opened. [3, 4] .
In this study, patients who underwent ureteroneocystostomy with LGT and STING due to VUR are evaluated in terms of radiographic, scintigraphic, laboratory and bladder functions and we aim to determine the effectiveness of each treatment.
METHODS
In this study, 106 patients who underwent ureteroneocystostomy with STING and LGT due to VUR were evaluated between January 2002 -January 2010 in Erciyes University Faculty of Medicine's Pediatric Surgery Department.
In this study, patients with a mean age of 7.5 ± 4 (0-17 years) who underwent ureteroneocystostomy due to unilateral VUR were evaluated. Bilateral VUR patients, one-sided VUR patients who underwent surgery with other anti-reflux techniques, and patients with chronic renal failure and neurogenic bladder were excluded from the study.
Patients in the 0-17 years age range (mean age 7.5 ± 4 years) were divided into 3 groups as 0-12 months, 13-60 months, and older than 60 months. The relationship among the age groups and presenting symptoms, and accompanying urological pathologies were evaluated. Patients' age, gender, presenting symptoms, bladder dysfunction, signs, laboratory values, radiology, and scintigraphy findings were analyzed retrospectively. The USG PKE relation, scar relationship in DMSA, relationship between the results and treatment methods were evaluated according to grades of VUR.
According to the clinical and laboratory findings, three methods were applied in treatment: medical follow-up, STING and surgical correction. After 6 months, injected patients underwent VUR control with VCUG. Injection and ureteroneocystostomy were applied in unhealed patients. The criteria for treatment success were evaluated as complete disappearance of VUR in control VCUG and decrease to stage I.
The SPSS 15.0 program was used for the statistical analysis of the findings of the study. In the evaluation of the data, average quantitative data were expressed as standard deviation while qualitative data were given as frequencies and percentages. The minimum level of statistical significance was considered as p <0.05.
RESULTS
Between January 2002 and January 2010, using LGT and STING, 32 male (30%) and 74 (70%) female, patients who underwent ureteroneocystostomy due to unilateral VUR were evaluated. The average age of the patients was SD 7.5 ± 4 (0-17 years).
When the age and the causes of the patients were evaluated, it was found that patients in the 0-12 months group applied with complaints of fever, vomiting, anxiety, and urinary tract infection. Patients in the 13-60 months age group applied mostly due to urinary tract infection (UTI) and patients aged over 60 months applied due to UTI and urinary incontinence ( Table 1) . Of the 106 patients with VUR, grade I-II VUR was detected in 23 patients (21%), grade III VUR was found in 42 patients (40%), grade IV VUR in 21 patients (20 %), and grade V VUR in 20 patients (19%). One hundred and six patients were evaluated in USG examination. The grades of VUR were compared to PKE in USG. PKE was found in 17% of patients with grade I-II VUR, in 29% of patients with grade III VUR, in 48% of patients with grade IV VUR, and in 90% of patients with grade V VUR. In a total of 106 patients, PKE was found in 44 patients (42%). In the comparison of grade of VUR and PKE in USG a statistically significant difference was found (p <0.05). The detailed findings are given in (Table 2) . (57) 11 (52) 4 (20) 52 (49) STING, n (%)
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LGT LGT is an open surgery technique which is frequently used in patients with unilateral VUR [1, 2] . In this study, all patients who underwent open surgery were operated on by LGT.
In patients with recurrent UTI, VUR was detected at a ratio of 38% by Alon et al. [5] , at 39% by Hoberman et al., and at 31% by McKerrow et al. [7] . In this study, 69 patients with VUR (65%) were treated due to UTI. As a result of the low socio-economic levels of patients, lack of follow-up and treatment and poor hygiene, UTI was found to be higher than in the literature.
Although VUR may be an isolated anomaly (primary VUR), it may also occur along with other congenital anomalies (secondary VUR) [8, 9] . VUR has been reported with many additional abnormalities. Multicystic dysplastic kidney, renal agenesis, and renal ectopia are the most frequently reported [10] . In the study of Öksüz [11] , VUR was detected in 72 of 140 patients (51%), and it was reported together with additional urological pathologies. In this study 60 (57%) additional urologic pathologies were identified among 106 patients. DSD, in this study, was one of the most frequently detected pathologies in patients with VUR. Thus, DSD should be investigated in patients with voiding dysfunction and VUR.
It has been stated in recent studies that VUR occurs as a result of an underlying abnormality [12] . Reducing grade of VUR and the treatment of reflux are more difficult in patients with bladder dysfunction [13] . Soygur et al. [14] , by means of urodynamic evaluation, detected voiding dysfunction in 73% of patients with bilateral VUR. In the literature, in patients with VUR and bladder dysfunction, overactive bladder, neurogenic bladder, and DSD were the most common disorders of bladder function [13] . In the study by Mayo et al. [15] , VUR was detected in 50% of 30 children with DSD detected in urodynamic evaluation. In this study, 70 of 82 patients (85%) who were toilet trained underwent EMG uroflow and DSD was detected in 23 of them (33%). Evaluation of accompanying unstable bladder was not carried out for patients who did not undergo routine urodynamics. Ureteroneocystostomy was applied with LGT in 14 of 23 patients with DSD (61%); six of them (26%) were given more than one injection. DSD was shown to reduce the success of treatment of VUR in our study.
It is important to perform imaging studies for the detection of VUR in children in high-risk groups. To detect VUR with USG, a sufficient amount of urine is required to puff up the renal pelvis. It is not very reliable in grade I, II, and III VUR where USG with ureteropelvic dilatation is not possible [16] . However with USG, only a high degree of reflux can be detected. Salih and Haberlik [17] , in two separate studies, detected a 90% success rate in grade I,II, and a 100% success rate in grade III VUR. In the study by Uner et al. [18] , 120 ureters in VUR patients were evaluated, and PKE was detected in USG In this study, the grade of VUR of patients were compared with PKE in USG. PKE was detected in 4 (17%) patients with grade I-II VUR, in 12 (29%) patients with grade III VUR, in 10 (48%) patients with grade IV VUR, and in 18 (90%) patients with grade V VUR. PKE was detected in 44 (42%) of 106 patients (p<0.05). The VUR grades and USG findings are consistent with those in the literature. USG is beneficial as VUR grade increases; therefore we suggest that VUR must be investigated in patients in whom PKE is detected.
The importance of the relationship among UTI, VUR and renal scarring is known. One third of children, surveyed because of UTI had VUR. One third of patients with VUR had kidney damage [19] . Lee et al. [20] , when they retrospectively analyzed the records of 220 children under the age of 2 who experienced UTI for the first time, detected renal damage disorder in low grade VUR (I-II) at 38%, and in high grade (III, IV, V) VUR at 88%. They suggested that there is a direct relationship between grade of VUR and kid- ney damage. In another study, It was reported that the grade of VUR is directly associated with renal scarring [14] . There are a number of studies indicating a proportional relationship between renal parenchymal damage and grade of VUR [22] . In this study, scarring was detected in 10 (43%) patients with grade I-II VUR, 18 (43%) patients with grade III VUR, 10 (48%) patients with grade IV VUR, and in 16 (80%) patients with grade V VUR. It was found that there is a statistically significant relationship between grade of VUR and scarring (p <0.05). Macedo et al. [23] , in their examination of 45 patients with VUR, found scarring in 32 patients (71%). In this study, renal scarring was detected in 54 of 106 patients (51%). The reason for the high detection of renal scarring in some degrees of reflux according to the literature is considered to be due to the fact that complicated cases are referred to hospitals with more advanced facilities.
Conservative treatment approaches in the treatment of VUR have steadily gained popularity. However, antireflux surgery remains important. Also, endoscopic methods, especially in the treatment of low grade of VUR, have been suggested as an alternative to open surgery [24] [25] [26] . Capozza and Caione [24] , published a report indicating the success rate of injection as 95% in patients with grade II VUR, 71% in patients with grade III VUR, and 43% in patients with grade IV VUR.
Similarly, Capozza et al. [24] , in their study, reported a success rate of 87% in patients with grade II VUR, of 75% in patients with grade III VUR, and of 41% in patients with grade IV VUR. In the study by Lackgren et al. [25] , a success rate of 78% was achieved in patients with grade II-III VUR, and of 66% in patients with grade IV VUR. Although endoscopic administration was performed at patients of low-grade VUR in our study due to the UTI and development of renal scarring although antibiotic prophylaxis. Currently conservative treatment is based on the understanding that VUR can resolve spontaneously, mostly in young patients with low-grade reflux. Resolution is approximately 80% in VUR grade I-II and 30-50% in VUR grade III-V within 4-5 yr of follow-up. Spontaneous resolution is low for bilateral high-grade reflux [26, 27] . In their study, Karakurt et al. [28] reviewed 109 patients who underwent injection and ureteroneocystostomy 1-4 times. The total success rate was founded to be 83%. In this study, among the patients who had 1-3 injections and ureteroneocystostomy by LGT, 20 (87%) patients with grade I-II VUR, 31 (74%) patients with grade III VUR, 17 (81%) patients with grade IV VUR, 18 (90%) patients with grade V VUR and 86 (81%) patients of 106 in total recovered completely and in 20 (19%) patients grade of VUR decreased.
In conclusion, it was observed that in patients with grade I, II, and III VUR, if there is no additional urological malformation, treatment with the STING method has a high success rate. It was detected that in patients with grade IV and V VUR, the success rate of the STING method is lower and treatment with ureteroneocystostomy is higher. It was determined that in those who underwent ureteroneocystostomy by LGT, especially on its own, VUR surgical treatment is an effective option which has minimal morbidity and a high success rate. It was determined that in VUR patients with DSD, the success rate rises in VUR treatment when it is combined with DSD treatment.
